Should U.S. biotech companies be allowed to sell to China's police force?
Illustration by Daniel Garcia
On December 13, 2019, in a cavernous meeting hall in the Chinese seaside city of Xiamen, Richard Selden took the stage to show off his company’s revolutionary technology: rapid DNA testing.
Top: Richard Selden delivers a presentation on the ANDE device, December 13, 2019. Bottom: Conference attendees examine ANDE's machine. Credit: 邯郸网警
Wearing a red tie that matched the decor, Selden, the founder of ANDE, explained how the large black box can take a single sample and deliver acc
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from Andrew Peaple.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
In an excerpt from his new book, Nicolas Niarchos examines how China and the Democratic Republic of Congo negotiated an infrastructure-for-commodities agreement involving two large Chinese state-owned enterprises and unlikely private sector partner.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy
